|
- A unique presentation of novel functional radionuclide imaging and therapies for the location and treatment of neuroendocrine tumors
- Discusses embryology and classification, molecular genetics, physics and technology in addition to the most up-to-date radiology and management strategies
- Represents a collaborative effort endocrinologists, radiologists, oncologists, geneticists and surgeons
Based on the most novel approaches and cutting-edge clinical and scientific information regarding radionuclide imaging and therapies for neuroendocrine tumors, this clinical guidebook represents a unique collaborative effort between endocrinologists, nuclear physicians, oncologists, surgeons, physicists, radio-pharmacists and geneticists. It begins with the embryology, classification and molecular genetics of gastroenteropancreatic neuroendocrine tumors and carcinoids, chromaffin cell tumors, and MEN1- and MEN2-related tumors. Following a chapter on radiopharmaceuticals in neuroendocrine imaging, it turns to the physics and technology of current and cutting-edge radiology, including SPECT/CT and PET/CT and PET/MR. Discussing of radionuclide imaging covers the tumors mentioned above, as well as pulmonary and thymic neuroendocrine tumors and medullary thyroid carcinoma. A presentation of radionuclide therapies follows, including 131I-MIBG therapy, somatostatin receptor-based therapy, and alpha radionuclide therapy, as well as the role of nanoparticles. Comprehensive and up-to-date, Diagnostic and Therapeutic Nuclear Medicine for Neuroendocrine Tumors will assist and guide physicians who encounter patients with these conditions, either from a diagnostic or therapeutic standpoint, and particularly emphasizes the current and emerging medical devices and imaging and therapeutic options. Table of Contents- Classification of Neuroendocrine Neoplasms
- Molecular Genetics of Pheochromocytoma and Paraganglioma
- Molecular Genetics of MEN1-Related Neuroendocrine Tumors
- Molecular Genetics of MEN2-Related Neuroendocrine Tumours
- Molecular Genetics of Neuroblastoma
- Molecular Genetics of Gastroenteropancreatic Neuroendocrine Tumours
- Current and Future Radiopharmaceuticals in Neuroendocrine Tumor Imaging
- SPECT/CT, PET/CT and PET/MR Principles
- Internal Dosimetry: Principles and Applications to NET
- Principles and Application of Molecular Imaging for Personalized Medicine and Guiding Interventions in Neuroendocrine Tumors
- Tumor Metabolism and Metabolomics of Pheochromocytomas and Paragangliomas
- Radionuclide Imaging of Pheochromocytoma and Paraganglioma in the Era of Multi-omics
- Radionuclide Imaging of Head and Neck Paragangliomas
- Radionuclide Imaging of Chromaffin Cell Tumors
- Radionuclide Imaging of Gastrointestinal Neuroendocrine Tumors
- Radionuclide Imaging of Pancreatic Neuroendocrine Tumours
- Radionuclide Imaging of Pulmonary and Thymic Neuroendocrine Tumors
- Radionuclide Imaging of Medullary Thyroid Carcinoma
- Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors
- Alpha Radionuclide Therapy: Principles and Applications to NETs
- Nanoparticles for Radionuclide Imaging and Therapy: Principles
|
